4-acetylphenyloxooxazolidinylmethylacetamide manufacturers
- Dup-721
-
-
2026-08-27
- CAS:104421-21-8
- Min. Order: 1KG
- Purity: 98
- Supply Ability: 1000 KG
- Dup-721
-
- $30.00
-
2026-07-04
- CAS:104421-21-8
- Purity: 99.84%
- Supply Ability: 10g
|
| | 4-acetylphenyloxooxazolidinylmethylacetamide Basic information |
| Product Name: | 4-acetylphenyloxooxazolidinylmethylacetamide | | Synonyms: | 4-acetylphenyloxooxazolidinylmethylacetamide;DuP-721;N-[[(5S)-2-Oxo-3-(4-acetylphenyl)-5α-oxazolidinyl]methyl]acetamide;N-[[(5S)-3-(4-Acetylphenyl)-2-oxooxazolidin-5-yl]methyl]acetamide;N-[[(5S)-3-(4-Acetylphenyl)-2-oxooxazolidin-5α-yl]methyl]acetamide;Dup-721,M. tuberculosis,anti-tuberculosis,Mycobacterium tuberculosis,Inhibitor,M. intracellulare,inhibit,M. kansassi,Dup 721,Dup721,Antibiotic,Bacterial;N-{[(5S)-3-(4-acetylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide;Dup-721, 10 mM in DMSO | | CAS: | 104421-21-8 | | MF: | C14H16N2O4 | | MW: | 276.29 | | EINECS: | | | Product Categories: | | | Mol File: | 104421-21-8.mol |  |
| | 4-acetylphenyloxooxazolidinylmethylacetamide Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO:100.0(Max Conc. mg/mL);361.94(Max Conc. mM) | | form | Solid | | color | White to off-white |
| | 4-acetylphenyloxooxazolidinylmethylacetamide Usage And Synthesis |
| Uses | DuP-721 is a broad spectrum and orally active antibacterial agent against a variety of clinically susceptible and resistant bacteria, especially M. tuberculosis[1]. | | Biological Activity | DuP-721 is a broad spectrum and orally active antibacterial agent against a variety of clinically susceptible and resistant bacteria, especially M. tuberculosis[1].
DuP-721 (1.5-4 μg/ml) inhibits equally the strains of Mycobacterium tuberculosis susceptible and resistant to conventional antituberculosis drug. And it does not show cross resistance to any of the anti-tuberculosis drugs tested[1].DuP-721 is inactive against M. avium and M. intracellulare at 250 μg/ml. It inhibits M. gordonoe and M. fortuitum at 3.9 μg/ml and M. kansassi and M. scrofulaceum at 1.95 μg/ml and 15.6 μg/ml, respectively[1].
DuP-721 (oral gavage; 50-160 mg/kg) is protective against M. tuberculosis infection in mice. DuP-721 protects 100% of the infected animals at 50 mg/kg p.o. dose when administered daily for 17 days, and the same effect is observed at 160 mg/kg dose when the drug is administered only on day 11 and 12 post infection[1]. | | in vivo | DuP-721 (oral gavage; 50-160 mg/kg) is protective against M. tuberculosisinfection in mice. DuP-721 protects 100% of the infected animals at 50 mg/kg p.o. dose when administered daily for 17 days, and the same effect is observed at 160 mg/kg dose when the drug is administered only on day 11 and 12 post infection[1]. | | References | [1]. Affiliatio, et al. Antimycobacterial activities of oxazolidinones: a review. Infect Disord Drug Targets. 2006 Dec;6(4):343-54. |
| | 4-acetylphenyloxooxazolidinylmethylacetamide Preparation Products And Raw materials |
|